DZK Recommendations for Tuberculosis, BCG and COVID-19 in Germany (Official Abbreviation of Coronavirus Disease 2019 Caused by the New Coronavirus SARS-CoV-2)

被引：4
|
作者：
Otto-Knapp, R. [1 ]
Haecker, B. [1 ]
Breuer, C. [1 ,2 ]
Diel, R. [1 ,3 ]
Kaufmann, S. H. E. [4 ]
Korr, G. [5 ]
Pfeiffer, M. [1 ,6 ,7 ]
Schaberg, T. [1 ]
Schoenfeld, N. [1 ,8 ]
Witte, P. [1 ,9 ]
Bauer, T. [1 ,7 ,8 ]
机构：
[1] Deutsch Zentralkomitee Bekampfung TB eV DZK, Walterhoferstr 11,Haus Q, D-14165 Berlin, Germany
[2] Gesundheitsamt Dresden, Dresden, Germany
[3] Airway Dis Ctr North ARCN, LungenClin Grosshansdorf, Grosshansdorf, Germany
[4] Max Planck Inst Infekt Biol, Berlin, Germany
[5] Bundesminist Gesundheit, Berlin, Germany
[6] Univ Klinikum Regensburg, Klin Donaustauf, Regensburg, Germany
[7] Deutsch Gesell Pneumol eV DGP, Leipzig, Germany
[8] Lungenklin Heckeshorn, Helios Klinikum Emil von Behring, Berlin, Germany
[9] Univ Klinikum Johannes Wesling Minden, Inst Krankenhaushyg Muhlenkreiskliniken, Minden, Germany
来源：
PNEUMOLOGIE | 2020年 / 74卷 / 07期
关键词：
VACCINE; MENINGITIS; TRIALS;
D O I：
10.1055/a-1199-6721
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：412 / 416
页数：5
相关论文
共 50 条
  • [21] The latent period of coronavirus disease 2019 with SARS-CoV-2 B.1.617.2 Delta variant of concern in the postvaccination era
    Ma, Tao
    Ding, Songning
    Huang, Rui
    Wang, Hengxue
    Wang, Junjun
    Liu, Jiacheng
    Wang, Jian
    Li, Jie
    Wu, Chao
    Fan, Huafeng
    Zhou, Nan
    IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (07)
  • [22] Effectiveness of BNT162b2 mRNA Coronavirus Disease 2019 (COVID-19) Vaccine Against Acquisition of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Healthcare Workers in Long-Term Care Facilities: A Prospective Cohort Study
    Muhsen, Khitam
    Maimon, Nimrod
    Mizrahi, Ami
    Bodenheimer, Omri
    Cohen, Dani
    Maimon, Michal
    Grotto, Itamar
    Dagan, Ron
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E755 - E763
  • [23] Lack of Difference in Tocilizumab Efficacy in the Treatment of Severe COVID-19 Caused by Different SARS-CoV-2 Variants
    Oliynyk, Oleksandr
    Barg, Wojciech
    Oliynyk, Yanina
    Dubrov, Serhij
    Gurianov, Vitaliy
    Rorat, Marta
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (07):
  • [24] SARS-COV-2 (COVID-19): Cellular and biochemical properties and pharmacological insights into new therapeutic developments
    Parlakpinar, Hakan
    Gunata, Mehmet
    CELL BIOCHEMISTRY AND FUNCTION, 2021, 39 (01) : 10 - 28
  • [25] COVID-19 pandemic predictions using the modified Bateman SIZ model and observational data for Heidelberg, Germany: Effect of vaccination with a SARS-CoV-2 vaccine, coronavirus testing and application of the Corona-Warn-App
    Braun, Peter
    Haffner, Steffen
    Woodcock, Barry G.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2020, 58 (08) : 417 - 425
  • [26] An update on the impact of SARS-CoV-2 pandemic public awareness on cancer patients' COVID-19 vaccine compliance: Outcomes and recommendations
    Souan, Lina
    Sughayer, Maher A.
    Abu Alhowr, Maha
    Ammar, Khawlah
    Bader, Sara Al
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [27] SARS-CoV-2 (COVID-19) vaccination in dermatology patients on immunomodulatory and biologic agents: Recommendations from the Australasian Medical Dermatology Group
    Wang, Charlie
    Rademaker, Marius
    Tate, Bruce
    Baker, Christopher
    Foley, Peter
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 (02) : 151 - 156
  • [28] Circulating eosinophils associated with responsiveness to COVID-19 vaccine and the disease severity in patients with SARS-CoV-2 omicron variant infection
    Zhu, Zhuxian
    Cai, Jixu
    Tang, Qiang
    Mo, Yin-yuan
    Deng, Tiantian
    Zhang, Xiaoyu
    Xu, Ke
    Wu, Beishou
    Tang, Haicheng
    Zhang, Ziqiang
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [29] Corona virus SARS-CoV-2 disease COVID-19: Infection, prevention and clinical advances of the prospective chemical drug therapeutics
    Chhikara, Bhupender S.
    Rathi, Brijesh
    Singh, Jyoti
    Poonam
    CHEMICAL BIOLOGY LETTERS, 2020, 7 (01): : 63 - 72
  • [30] Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence
    Esposito, Susanna
    Caminiti, Caterina
    Giordano, Rosanna
    Argentiero, Alberto
    Ramundo, Greta
    Principi, Nicola
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345